Validity, reliability, and sensitivity to change of a French version of the arthritis impact measurement scales 2 (AIMS2) in patients with rheumatoid arthritis treated with methotrexate.

Date publication

janvier 1996

Journal

The Journal of rheumatology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis

Tous les auteurs :
Pouchot J, Guillemin F, Coste J, Brégeon C, Sany J

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/8838508

Résumé

To develop and validate a cross cultural version of the Arthritis Impact Measurement Scales 2 (AIMS2) to be used by French speaking populations.

Mots clés

Activities of Daily Living, Antirheumatic Agents, therapeutic use, Arthritis, Rheumatoid, drug therapy, Cohort Studies, Demography, Factor Analysis, Statistical, Female, France, Humans, Male, Methotrexate, therapeutic use, Middle Aged, Quality of Life, Reproducibility of Results, Sensitivity and Specificity, Severity of Illness Index, Surveys and Questionnaires

Référence

J. Rheumatol.. 1996 Jan;23(1):52-60